Account Type**** *******Account Owner******* ******Account Opps/Deals******** *****Closed Won • Oct 24***K $Closed
******** ********Worked in execs roles at *** together from 2021-2024**** *******Worked in the same department at *** together from 2021-2024
Johnson Johnson Innovative MedicineSr. Director, US DMPK Development Head and Therapeutic Area Lead for OncologyJan 18 - PresentMerckExecutive Director, ADMEJan 05- Nov 16Massachusetts Institute Of TechnologyPostdoctoral FellowJan 97- Jan 99
Scott SchliebnerVice President And Global Head Drug Development ConsultingView Profile, scott schliebnerScott SchliebnerVice President And Global Head Drug Development ConsultingView Profile, scott schliebnerAviad LichtenstadtVP R DView Profile, aviad lichtenstadt